ENCRYPTED SHIELD Trademark

Trademark Overview


On Thursday, September 1, 2022, a trademark application was filed for ENCRYPTED SHIELD with the United States Patent and Trademark Office. The USPTO has given the ENCRYPTED SHIELD trademark a serial number of 97574537. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, May 14, 2024. This trademark is owned by Autonomous Therapeutics, Inc.. The ENCRYPTED SHIELD trademark is filed in the Pharmaceutical Products category with the following description:

Therapeutic pharmaceuticals containing nucleic acids for the treatment of infectious diseases, viruses, immunological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, psychiatric diseases and disorders, respiratory diseases and disorders, genetic diseases and disorders, and cancer; pharmaceutical preparations for the treatment of infectious diseases, viruses, immunological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, psychiatric diseases and disorders, respiratory diseases and disorders, genetic diseases and disorders, and cancer
encrypted shield

General Information


Serial Number97574537
Word MarkENCRYPTED SHIELD
Filing DateThursday, September 1, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, May 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesTherapeutic pharmaceuticals containing nucleic acids for the treatment of infectious diseases, viruses, immunological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, psychiatric diseases and disorders, respiratory diseases and disorders, genetic diseases and disorders, and cancer; pharmaceutical preparations for the treatment of infectious diseases, viruses, immunological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, psychiatric diseases and disorders, respiratory diseases and disorders, genetic diseases and disorders, and cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 20, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAutonomous Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20852

Trademark Events


Event DateEvent Description
Tuesday, September 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, June 18, 2023ASSIGNED TO EXAMINER
Monday, June 19, 2023NON-FINAL ACTION WRITTEN
Monday, June 19, 2023NON-FINAL ACTION E-MAILED
Monday, June 19, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 9, 2023NON-FINAL ACTION WRITTEN
Monday, October 9, 2023NON-FINAL ACTION E-MAILED
Monday, October 9, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 20, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, May 14, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, December 20, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, May 14, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE